QIAGEN Partners to Develop Novel Companion Diagnostic in Lung Cancer
Collaboration with Mirati Therapeutics targets MET gene mutations to personalize treatment
Collaboration with Mirati Therapeutics targets MET gene mutations to personalize treatment
In vitro diagnostic approved to support use of Bristol-Myers Squibb’s OPDIVO® for non-squamous non-small cell lung cancer
Discover SelectScience® video interviews and articles about the latest Alzheimer’s disease research methods
Leading UK clinician appointed to guide Sphere’s clinical programme
PowerCHO Advance™ Media is the latest addition to the company’s range of specialized, chemically defined, serum-free media for culturing Chinese Hamster Ovary cells
An article written by Vitl Life Science Solutions for SelectScience®
TATAA Biocenter also to introduce Swift Biosciences’ NGS products in its popular NGS training courses
Certified quality of analytical services for developers of biologics and biosimilars
Cobra and the CPI collaborate to develop an industrial manufacturing platform for adeno-associated virus production
Irvine Scientific announce the launch of BalanCDR CHO Feed 4
Integrated with nearly 600 EHR platforms to align clinical management with quality, utilization and financial performance goals
Laboratory expands access to innovative solutions for safer pregnancies and healthier babies in India
Novel strategy shortens time to heart attack diagnosis drastically, enabling faster start of treatment of patients and better use of healthcare resources
Lonza and Renova Therapeutics Announce Manufacturing Agreement for Clinical Supply of RT-100 Gene Therapy
Multi-phase collaboration to advance next-generation sequencing, single-cell biology, and bioinformatics Sample to Insight solutions
Roche Presents Updated Results for Investigational Cancer Immunotherapy Atezolizumab in Advanced Bladder Cancer
Hear from the winner of the Best New Drug Discovery Product of 2015, Thermo Fisher Scientific